Table S1.
Mean (SD) and median paid amounts for breast diagnostic procedures, all patients and by payer, in US dollars
| All patients N=875,526 |
Commerciala n=789,062 |
Medicareb n=73,768 |
Transitionc n=12,696 |
|||||
|---|---|---|---|---|---|---|---|---|
| Mean (SD) | Median | Mean (SD) | Median | Mean (SD) | Median | Mean (SD) | Median | |
| Diagnostic mammography | $349 ($492) | $234 | $354 ($490) | $239 | $297 ($518) | $172 | $347 ($477) | $229 |
| Tomosynthesis | $134 ($102) | $113 | $136 ($102) | $115 | $110 ($102) | $93 | $115 ($88) | $93 |
| Ultrasound | $132 ($134) | $95 | $137 ($135) | $100 | $76 ($109) | $54 | $112 ($120) | $83 |
| Molecular breast imaging | $296 ($422) | $135 | $299 ($406) | $133 | $291 ($530) | $190 | $175 ($165) | $77 |
| Magnetic resonance imaging | $1,197 ($1,054) | $1,021 | $1,228 ($1,054) | $1,073 | $875 ($1,005) | $615 | $1,130 ($984) | $954 |
| Biopsy | $1,938 ($2,343) | $1,211 | $1,940 ($2,177) | $1,246 | $1,901 ($3,424) | $918 | $2,064 ($2,862) | $1,154 |
| Surgical biopsy | ||||||||
| Ultrasound-guided localization | $1,909 ($2,199) | $1,245 | $1,902 ($2,002) | $1,276 | $1,951 ($3,438) | $971 | $2,075 ($2,466) | $1,105 |
| Other surgical procedures | $356 ($675) | $193 | $361 ($676) | $203 | $290 ($599) | $155 | $502 ($993) | $236 |
| FNA biopsy | ||||||||
| Ultrasound-guided FNA | $249 ($467) | $153 | $251 ($467) | $154 | $240 ($480) | $146 | $208 ($406) | $118 |
| Other FNA | $217 ($286) | $172 | $220 ($298) | $173 | $193 ($135) | $159 | $173 ($82) | $181 |
| Core biopsy | ||||||||
| Ultrasound-guided core | $1,032 ($1,200) | $694 | $1,036 ($1,077) | $712 | $999 ($1,950) | $578 | $1,041 ($1,407) | $695 |
| Procedures ancillary to biopsy | ||||||||
| Follow-up office visit | $735 ($891) | $451 | $720 ($886) | $432 | $811 ($926) | $570 | $783 ($807) | $516 |
| Pathology | $1,264 ($2,463) | $501 | $1,243 ($2,371) | $502 | $1,381 ($3,075) | $471 | $1,682 ($2,882) | $660 |
| Anesthesia | $1,120 ($1,146) | $776 | $1,178 ($1,143) | $843 | $702 ($1,058) | $356 | $1,166 ($1,312) | $793 |
Notes:
Commercial: data from active employees, early retirees, health care coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985 continues, and dependents insured by employer-sponsored plans (i.e., persons not eligible for Medicare).
Medicare/Medicare supplemental: data from individuals enrolled in Medicare who also have group health insurance coverage paid for by a current or former employer.
Transition: data for patients who transitioned during the reporting period from having only commercial insurance to then having Medicare plus a supplemental insurance paid for by their current or former employer.
Abbreviation: FNA, fine needle aspiration.